CA8676EP1086 - Common Stock

Overall **STKL** gets a fundamental rating of **2** out of 10. We evaluated **STKL** against 93 industry peers in the **Food Products** industry. While **STKL** is still in line with the averages on profitability rating, there are concerns on its financial health. **STKL** has a expensive valuation and it also scores bad on growth.

In the past year **STKL** had a positive cash flow from operations.

Of the past 5 years **STKL** 4 years had a positive operating cash flow.

With a **Return On Equity** value of **-95.91%**, **STKL** is not doing good in the industry: **76.92%** of the companies in the same industry are doing better.

The **Average Return On Invested Capital** over the past 3 years for **STKL** is below the industry average of **8.66%**.

The 3 year average ROIC (**4.69%**) for **STKL** is below the current ROIC(**8.07%**), indicating increased profibility in the last year.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -26.15% | ||

ROE | -95.91% | ||

ROIC | 8.07% |

ROA(3y)-9.36%

ROA(5y)-3.51%

ROE(3y)-34.91%

ROE(5y)-17.74%

ROIC(3y)4.69%

ROIC(5y)N/A

The **Operating Margin** of **STKL** (**8.97%**) is better than **73.63%** of its industry peers.

The **Gross Margin** of **STKL** (**21.32%**) is comparable to the rest of the industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 8.97% | ||

PM (TTM) | N/A | ||

GM | 21.32% |

OM growth 3Y68.62%

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y12.9%

GM growth 5Y15.71%

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so **STKL** is still creating some value.

Compared to 1 year ago, **STKL** has more shares outstanding

The number of shares outstanding for **STKL** has been increased compared to 5 years ago.

Compared to 1 year ago, **STKL** has a worse debt to assets ratio.

Based on the Altman-Z score of **1.27**, we must say that **STKL** is in the distress zone and has some risk of bankruptcy.

With a **Altman-Z score** value of **1.27**, **STKL** is not doing good in the industry: **65.93%** of the companies in the same industry are doing better.

A Debt/Equity ratio of **1.28** is on the high side and indicates that **STKL** has dependencies on debt financing.

The **Debt to Equity ratio** of **STKL** (**1.28**) is worse than **76.92%** of its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 1.28 | ||

Debt/FCF | N/A | ||

Altman-Z | 1.27 |

ROIC/WACC1.02

WACC7.87%

A Current Ratio of **1.22** indicates that **STKL** should not have too much problems paying its short term obligations.

With a **Current ratio** value of **1.22**, **STKL** is not doing good in the industry: **61.54%** of the companies in the same industry are doing better.

A Quick Ratio of **0.63** indicates that **STKL** may have some problems paying its short term obligations.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 1.22 | ||

Quick Ratio | 0.63 |

The earnings per share for **STKL** have decreased strongly by **-66.67%** in the last year.

The **Revenue** has decreased by **-7.43%** in the past year.

Measured over the past years, **STKL** shows a decrease in **Revenue**. The Revenue has been decreasing by **-4.27%** on average per year.

EPS 1Y (TTM)-66.67%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-60%

Revenue 1Y (TTM)-7.43%

Revenue growth 3Y-7.22%

Revenue growth 5Y-4.27%

Sales Q2Q%-18.33%

Based on estimates for the next years, **STKL** will show a very strong growth in **Earnings Per Share**. The EPS will grow by **49.55%** on average per year.

The **Revenue** is expected to grow by **10.83%** on average over the next years. This is quite good.

EPS Next Y-9.82%

EPS Next 2Y49.55%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year12.53%

Revenue Next 2Y10.83%

Revenue Next 3YN/A

Revenue Next 5YN/A

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

The **Price/Earnings** ratio is **130.25**, which means the current valuation is very expensive for **STKL**.

The average S&P500 **Price/Earnings** ratio is at **29.18**. **STKL** is valued rather expensively when compared to this.

With a **Price/Forward Earnings** ratio of **33.28**, **STKL** can be considered very expensive at the moment.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 130.25 | ||

Fwd PE | 33.28 |

Compared to the rest of the industry, the **Enterprise Value to EBITDA** ratio of **STKL** indicates a somewhat cheap valuation: **STKL** is cheaper than 69.23% of the companies listed in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | N/A | ||

EV/EBITDA | 10.66 |

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y49.55%

EPS Next 3YN/A

No dividends for **STKL**!.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

**SUNOPTA INC**

NASDAQ:STKL (8/2/2024, 7:00:01 PM)

After market: 5.21 0 (0%)**5.21**

**-0.04 (-0.76%) **

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupFood, Beverage & Tobacco

GICS IndustryFood Products

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap621.76M

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 130.25 | ||

Fwd PE | 33.28 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -26.15% | ||

ROE | -95.91% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 8.97% | ||

PM (TTM) | N/A | ||

GM | 21.32% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.88

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 1.28 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 1.22 | ||

Quick Ratio | 0.63 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)-66.67%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next Y-9.82%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-7.43%

Revenue growth 3Y-7.22%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y